{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -10.714283, "regularMarketPrice": 3.0, "exchange": "FRA", "shortName": "HLS THERAPEUTICS INC.", "longName": "HLS Therapeutics Inc.", "messageBoardId": "finmb_303684187", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "marketState": "REGULAR", "esgPopulated": false, "sharesOutstanding": 32350500, "bookValue": 3.873, "fiftyDayAverage": 4.5054, "fiftyDayAverageChange": -1.5054002, "fiftyDayAverageChangePercent": -0.3341324, "twoHundredDayAverage": 6.5311, "twoHundredDayAverageChange": -3.5310998, "twoHundredDayAverageChangePercent": -0.5406593, "marketCap": 104627400, "priceToBook": 0.77459335, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1605769200000, "priceHint": 4, "regularMarketChange": -0.3599999, "regularMarketTime": 1683892036, "regularMarketDayHigh": 3.0, "regularMarketDayRange": "2.98 - 3.0", "regularMarketDayLow": 2.98, "regularMarketPreviousClose": 3.36, "bid": 2.98, "ask": 3.26, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 3.0, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.01999998, "fiftyTwoWeekLowChangePercent": 0.006711403, "fiftyTwoWeekRange": "2.98 - 11.2", "fiftyTwoWeekHighChange": -8.2, "fiftyTwoWeekHighChangePercent": -0.73214287, "fiftyTwoWeekLow": 2.98, "fiftyTwoWeekHigh": 11.2, "earningsTimestamp": 1683808200, "earningsTimestampStart": 1691584200, "earningsTimestampEnd": 1692016200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.64, "symbol": "74D.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "10 Carlson Court", "address2": "Suite 701", "city": "Etobicoke", "state": "ON", "zip": "M9W 6L2", "country": "Canada", "phone": "647-495-9000", "fax": "416-213-0045", "website": "https://www.hlstherapeutics.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; Vascepa, an icosapent ethyl capsules for cardiovascular disease; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the United States marketing rights of Absorica, a commercial stage dermatology product; Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.", "fullTimeEmployees": 99, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gregory David Gubitz B.A., L.L.B., LL.B", "age": 65, "title": "Co-Founder & Chairman", "yearBorn": 1957, "fiscalYear": 2021, "totalPay": {"raw": 289936, "fmt": "289.94k", "longFmt": "289,936"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tim  Hendrickson M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2021, "totalPay": {"raw": 402328, "fmt": "402.33k", "longFmt": "402,328"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sanjiv  Sharma", "age": 66, "title": "Chief Commercial Officer", "yearBorn": 1956, "fiscalYear": 2021, "totalPay": {"raw": 486691, "fmt": "486.69k", "longFmt": "486,691"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ryan C. Lennox B.A., J.D.", "age": 41, "title": "Sr. VP of Legal, HR & Compliance and Corp. Sec.", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David  Spence", "age": 54, "title": "VP & Corp. Controller", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 3, "shareHolderRightsRisk": 5, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}